[{"indications": "Indications\u00a0hypertension (see also notes above)", "name": "EPROSARTAN", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "2 Cardiovascular system", "2.5 Hypertension and heart failure", "2.5.5 Drugs affecting the renin-angiotensin system", "2.5.5.2 Angiotensin-II receptor antagonists"], "cautions": "Cautions\u00a0see notes above", "side-effects": "Side-effects\u00a0see notes above; also flatulence, hypertriglyceridaemia,\r\narthralgia, rhinitis; rarely headache, asthenia,\r\nanaemia, hypersensitivity reactions (including rash, pruritus, urticaria); very rarely nausea", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/85176.htm", "doses": ["600\u00a0mg once daily (elderly over 75 years, initially 300\u00a0mg\r\nonce daily); if necessary increased after 2\u20133 weeks to 800\u00a0mg once\r\ndaily"], "pregnancy": "Pregnancy\u00a0\n(From 2.5.5.2 Angiotensin-II receptor antagonists: British National Formulary)\nPregnancy\u00a0Angiotensin-II receptor antagonists should be avoided in pregnancy unless essential. They may adversely affect fetal and neonatal blood pressure control and renal function; skull defects and oligohydramnios have also been reported."}]